Researchers at Mass General Brigham report that racial and ethnic minority patients continue to be disproportionally affected by COVID-19.
- Among patients with severe COVID-19 who were treated with ventilators in intensive care units, most survived and ultimately recovered consciousness, but this took more than three weeks for some.
- Patients with low blood oxygen levels tended to take a longer time to recover consciousness.
Brian L. Edlow, MD
We found that low blood oxygen levels correlated with the time to recovery, even after accounting for other factors such as exposure to sedatives.
Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital
BOSTON – During the first wave of the COVID-19 pandemic, many patients in intensive care units did not recover consciousness after their breathing tubes were removed and their sedation was stopped, leaving clinicians and families with difficult decisions about whether to continue life-sustaining therapy. Remarkably, the majority of these patients ultimately recovered consciousness, but often after days or even weeks. To help provide accurate prognostic information moving forward, a team at Massachusetts General Hospital (MGH), NewYork-Presbyterian/Columbia University Irving Medical Center, Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center launched a multicenter study to better understand the recovery timeline and the causes of delayed recovery of consciousness in patients with severe COVID-19.
The study, which is published in the Annals of Neurology, involved a retrospective analysis of 795 patients with severe COVID-19 who were treated with mechanical ventilators in the intensive care units of the investigators’ medical centers for at least six days. After respiratory support ended, clinicians performed daily assessments to see whether patients could respond purposefully to a verbal command, a standard measure of consciousness.
Of the 795 patients, 72% survived and ultimately recovered consciousness prior to hospital discharge. For those who survived, 25% recovered consciousness 10 or more days after ventilator support was stopped, and 10% took more than three weeks to recover.
“When we examined the potential causes of delayed recovery of consciousness, we found that low blood oxygen levels correlated with the time to recovery, even after accounting for other factors such as exposure to sedatives,” says co–senior author Brian L. Edlow, MD, associate director of the Center for Neurotechnology and Neurorecovery at MGH and associate professor of neurology at Harvard Medical School. “This relationship was dose-dependent—the more episodes of low blood oxygen that a patient experienced, the longer it took them to wake up.”
Most patients had normal brain scans, suggesting that the prolonged time to recover consciousness was not related to stroke, swelling, or bleeding in the brain. “These observations were consistent across all three medical centers and during the first and second surges of the COVID-19 pandemic,” says Jan Claassen, MD, a co-leader of the study and associate professor of neurology at Columbia University Vagelos College of Surgeons and Physicians.
Additional research is needed to understand the mechanisms behind the link between low blood oxygen levels and prolonged time to recover consciousness. “We’ve seen similar phenomena in rare patients with cardiac arrest who were treated with hypothermia,” says Nicholas D. Schiff, MD, a co-leader of the study and the Jerold B. Katz Professor of Neurology and Neuroscience in the Feil Family Brain and Mind Research Institute and co-director of the Consortium for the Advanced Study of Brain Injury (CASBI) at Weill Cornell Medicine and an attending neurologist at NewYork-Presbyterian/Weill Cornell Medical Center. “Hypothermia appears to protect cardiac arrest patients from neurological damage in ways we still don’t understand. We’re now moving forward with studies aimed at uncovering common underlying mechanisms of neuroprotection that might connect these two groups of patients.”
Regardless of the underlying mechanisms yet to be uncovered, the study’s results could have an immediate clinical impact. “These findings provide us with more accurate information to guide families who are deciding whether to continue life-sustaining therapy in unconscious COVID-19 patients,” says Edlow. “The fact that delayed recovery of consciousness was consistently seen at three different medical centers, across two surges of COVID-19, suggests that we should consider the possibility of delayed recovery when making life-of-death decisions for these patients in the intensive care unit.”
The results may also be applied to critically ill patients with other medical conditions. “We are trying to determine whether the lessons learned from patients with severe COVID-19 can inform our approach to oxygenation targets and sedation management in the intensive care unit for the broad spectrum of patients who require mechanical ventilation,” says co-author Emery N. Brown, MD, PhD, professor of anesthesia at Harvard Medical School, anesthesiologist at MGH, and professor of medical engineering and computational neuroscience at Massachusetts Institute of Technology.
Co–first author Megan E. Barra, PharmD, a clinical pharmacy specialist in neurocritical care at MGH, notes that additional research is also needed to determine the degree of functional recovery in patients with COVID-19 or other conditions who experience prolonged unconsciousness after ventilator support is stopped. “We did not look at long-term recovery of cognition or functional independence in our study, but this is an important consideration for patients and their families,” she says.
Additional study co-authors include Greer Waldrop, MD, ScM; Seyed A. Safavynia, MD, PhD; Sachin Agarwal, MD, MPH; David A. Berlin, MD; Amelia K Boehme, PhD, MSPH; Daniel Brodie, MD; Jacky M. Choi, MPH; Kevin Doyle, MA; Joseph J. Fins, MD; Wolfgang Ganglberger, MSc; Katherine Hoffman, MS; Aaron M. Mittel, MD; David Roh, MD; Shibani S. Mukerji, MD, PhD; Caroline Der Nigoghossian, PharmD,; Soojin Park, MD; Edward J. Schenck, MD; John Salazar-Schicchi, MD; Qi Shen, PhD; Evan Sholle, MS; Angela G. Velazquez, MD; Maria C. Walline, MD; M. Brandon Westover, MD, PhD; Jonathan Victor, MD, PhD.
The study was supported by the James S. McDonnell Foundation.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2021, Mass General was named #5 in the U.S. News & World Report list of "America’s Best Hospitals."
Related News and Articles
- Press Release
- Apr | 1 | 2022
Simulation study predicts COVID-19 deaths will rebound sooner or later when all restrictions are lifted
With COVID-19 cases going down rapidly in the United States, is it possible to avoid trade-offs between returning to pre-pandemic lifestyles and increasing COVID-19-related deaths?
- Press Release
- Mar | 7 | 2022
Massachusetts General Hospital to participate in collaborative nationwide study to understand prolonged symptoms of COVID-19 and how to recover from them
- Press Release
- Mar | 1 | 2022
Almost all post-COVID neuropathy appears due to infection-triggered immune dysfunction that is potentially treatable.
- Press Release
- Feb | 24 | 2022
Newly diagnosed diabetes in patients with COVID-19 may simply be a transitory form of the blood sugar disorder
Researchers from Mass General shed light on whether newly diagnosed diabetes in COVID-19 patients is truly new or merely previously undiagnosed
- Press Release
- Feb | 23 | 2022
Study shows rapid improvement in children with MIS-C treated with drug first developed for celiac disease.